Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05073029
Other study ID # ENDO-7
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 10, 2019
Est. completion date November 10, 2019

Study information

Verified date October 2021
Source Bogomolets National Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main medical and social purpose of the project "It's trendy to be healthy!" is the promotion of healthy lifestyles and healthy eating among student youth. The relevance of this project is beyond doubt, as the WHO called obesity a non-communicable epidemic, and according to research by the Jane Schiller University of Germany (Germany), as mentioned above, Ukraine topped the list of the countries with high mortality due to malnutrition


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date November 10, 2019
Est. primary completion date September 10, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - medical students aged between 18-25 years; - presence of presence of vitamin D deficiency or insuficiency (serum total vit D3 level less than ); - signed informed consent. Exclusion Criteria: - regular intake of probiotics, prebiotics, antibiotics, anticonvulsants, calcium and vit. D supplements for 3 months prior the inclusion; - previously diagnosed allergy to gut microbiota-based therapy; gastrointestinal disorders including food allergy, gluten-sensitive enteropathy, ulcerative colitis; - suffering from any psychiatric illness; presence of diabetes mellitus, chronic cardiovascular or respiratory disease, an active malignant tumor or chronic infections; participation in another clinical trial; - pregnancy or lactation; - any condition thought to be associated with poor compliance (e.g., alcoholism or drug addiction) or any condition or circumstance that would, in the opinion of the investigator, prevent completion of the study or interfere with analysis of study results.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
nutrition program and modification of physical activity
nutrition program developed by a gastroenterologist-nutritionist and modification of physical activity (8000-10000 steps daily)
Dietary Supplement:
synbiotic (Fructooligosaccharides+Lactobacillus rhamnosus GG ATCC 53103, 4.0?109 colony forming units - CFU)
one synbiotic sachet (3g), BID, for 3 month traetment
vitamin D3
vitamin D3, oral, 2000IU BID, for 3 month treatment

Locations

Country Name City State
Ukraine Bogomolets National Medical University Kyiv
Ukraine Taras Shevchenko National University of Kyiv Kyiv

Sponsors (2)

Lead Sponsor Collaborator
Bogomolets National Medical University Taras Shevchenko National University of Kyiv

Country where clinical trial is conducted

Ukraine, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Rathus Assertiveness Schedule RAS is consists of 30 questions and is divided into five subgroups, according to the scores: 0-24: very insecure; 25-48: rather unsure than confident; 49-72: average confidence value; 73-96: self-confident and 97-120: overconfident. 90 days compared to baseline
Primary Changes in test "Diagnosis of situational and personal anxiety" Test " Diagnosis of situational and personal anxiety" by Ch. D. Spielberger consists of 20 statements that refer to anxiety as a state (state of anxiety, reactive (RA) or situational anxiety (SA)) and 20 statements to define anxiety as a disposition, personality traits (anxiety property). 90 days compared to baseline
Secondary weight weight in kg at 45 and 90 days compared to baseline
Secondary waist circumferences (WC) WC in cm at 45 and 90 days compared to baseline
Secondary body mass index (BMI) weight in kg and height in meters will be combined to report BMI in kg/m^2 at 45 and 90 days compared to baseline
Secondary muscle mass muscle mass (kg) using electronic scales-analyzers of body composition Tanita Scale BC-601 at 45 and 90 days compared to baseline
Secondary fat content fat content (%) using electronic scales-analyzers of body composition Tanita Scale BC-601 at 45 and 90 days compared to baseline
Secondary systolic blood pressure (SBP) Blood pressure is measured from the right hand while sitting with the help of a mercury barometer "OMRON". Blood pressure is taken twice at a 5-minute interval while seated for 5 minutes. at 45 and 90 days compared to baseline
Secondary diastolic blood pressure (DBP) Blood pressure is measured from the right hand while sitting with the help of a mercury barometer "OMRON". Blood pressure is taken twice at a 5-minute interval while seated for 5 minutes. at 45 and 90 days compared to baseline
Secondary HbA1c HbA1c in % 90 days compared to baseline
Secondary fasting plasma glucose (FPG) FPG in mmol/L 90 days compared to baseline
Secondary total cholesterol (TC) TC in mmol/L 90 days compared to baseline
Secondary Total vitamin D3 Total vitamin D3, ng/ml 90 days compared to baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1